REG - CVS Group plc - Exercise of Options and Total Voting Rights

CVSAnnouncement

31/08/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230831:nRSe8745Ka&default-theme=true

RNS Number : 8745K  CVS Group plc  31 August 2023

31 August 2023

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Total Voting Rights

CVS, one of the UK's leading providers of integrated veterinary services,
confirms that certain employees have exercised options during August under the
CVS Group 2019 SAYE Plan (2019/2023) totalling 834 ordinary shares of 0.2
pence each ("Ordinary Shares").

The sum of 834 new Ordinary Shares were issued to satisfy the balance of
Ordinary Shares arising from the SAYE Exercise.  Admission of the 834 new
Ordinary Shares has been satisfied by the Company's block listing admitted to
the London Stock Exchange on 30 December 2021.

Following the issue of these new Ordinary Shares, which rank pari passu in all
respects with the Company's existing Ordinary Shares, the Company has a total
issued share capital of 71,429,755 Ordinary Shares, each carrying one voting
right. The Company holds no Ordinary Shares in treasury and the total number
of voting rights is therefore 71,429,755.

This figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest, or a change to their interest, in the Company under the FCA's
Disclosure Guidance and Transparency Rules.

Contacts:

CVS Group plc
 
       via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser &
Broker)
+44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

   Berenberg (Joint Broker)
 
 +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial
PR)

Geoffrey Pelham-Lane
 
 +44 (0)7733 124 226

Ginny Pulbrook
 
        +44 (0)7961 315 138

 

About CVS Group plc (www.cvsukltd.co.uk (http://www.cvsukltd.co.uk/) )

CVS Group is an AIM-quoted fully-integrated provider of veterinary services
in the UK, with practices in Australia, the Netherlands and the Republic of
Ireland. CVS is focused on providing high quality clinical services to its
customers and their animals, with outstanding and dedicated clinical teams and
support colleagues at the core of its strategy.

The Group has c.500 veterinary practices across its four markets, including
nine specialist referral hospitals and 39 dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties), Crematoria
(providing pet cremation and clinical waste disposal for CVS and third-party
practices), Buying Groups and the Group's online retail business ("Animed
Direct").

The Group employs c.8,700 personnel, including c.2,250 veterinary surgeons
and c.3,200 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVRDDGDIGDXDGXG